Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 9—September 2026

Research

Dual PCR–Sanger Sequencing Assay for Simultaneous sqle-Based Identification and Resistance Detection in Trichophyton Species

Nissrine Abou-ChakraComments to Author , Karin M. Jørgensen, Karen Marie Thyssen Astvad, and Maiken Cavling Arendrup
Author affiliation: Statens Serum Institut, Copenhagen, Denmark (N. Abou-Chakra, K.M. Jørgensen, K.M.T. Astvad, M.C. Arendrup); Rigshospitalet, Copenhagen (M.C. Arendrup); University of Copenhagen, Copenhagen (M.C. Arendrup)

Main Article

Table 1

MICs determined using the EUCAST E.Def 11.0 reference method for dermatophytes in study of dual PCR–Sanger sequencing assay for simultaneous sqle-based identification and resistance detection in Trichophyton species†

Species SQLE amino acid alteration (intrinsic SNPs) Terbinafine MIC, mg/L
No. isolates
Modal MIC‡ Range
T. indotineae, n = 105
WT ND 0.03–0.06 3
L393F ND >4 1
L393S ND 0.5–1 3
F397L >4 2–>4 63
F397L/Y414H ND >4 1
F397L/A448T ND 4–>4 6
Q408L 2 1–4 20
F415C ND 1 1
F415L ND 0.5 1
A448T
ND
0.03–0.125
6
T. interdigitale, n = 26
WT 0.008/0.016 <0.004-0.06 21
L393F ND >4 1
L393S ND 0.25–1 3
F415L
ND
0.25
1
T. mentagrophytes ITS genotype DK-I, n = 1§
WT (SNPs: N276¶, F419 and T454)
ND
0.06
1
T. mentagrophytes ITS genotype DK-II, n = 4§
WT (SNPs: N276¶, F419 and P454)
ND
0.008–0.06
4
T. mentagrophytes ITS genotype III, n = 2§
WT (SNPs: N276¶, F419 and T454)
ND
0.016–0.03
2
T. mentagrophytes ITS genotype III*, n = 9§
WT (SNPs: N276¶, F419 and T454)
ND
0.008–0.03
9
T. mentagrophytes ITS genotype IV, n = 1§
WT (SNPs: K276¶, L419 and T454)
ND
0.03
1
T. mentagrophytes ITS genotype VII, n = 2§
WT (SNPs: N276¶, F419 and T454)
ND
0.016–0.03
2
T. rubrum, n = 285
WT 0.016 <0.004–0.06 143
Y110C¶ ND 0.008 1
I121M¶ ND 0.03 1
I121M/F415S ND 0.5 1
L335F/F415S ND 2 1
L393del ND 4 2
L393F ND >4 7
L393F/Y394del ND >4 2
L393S 0.5 0.25–2 15
S395_I396insS ND 0.5 3
F397I 1 0.25–1 11
F397L 4 1->4 78
Y414H ND 0.03–0.06 2
F415L ND 0.125 1
F415S ND 0.125–1 3
H440Y ND 0.016–0.125 9
A448T ND 0.03 1
A448V ND 0.004 1
L451P ND 0.125 1
C476Y
ND
0.016–0.03
2
T. soudanense, n = 2§
WT
ND
<0.004–0.008
2
T. tonsurans, n = 16§
WT
0.016
0.008–0.06
16
T. violaceum, n = 24§
WT
0.03
0.004–0.125
24
T. equinum, n = 1§
WT
ND
0.03
1
T. simii, n = 1§
WT
ND
<0.004
1
T. erinacei, n = 2§#
WT
ND
Not tested
2
T. concentricum, n = 1§#
WT
ND
Not tested
1
T. europaeum, n = 1§
WT
ND
0.03
1
T. benhamiae var. benhamiae/var. luteum, n = 10§ WT ND 0.004–0.06 10

†EUCAST tentative epidemiological cutoff values for terbinafine (0.125 mg/L for T. indotineae and 0.03 mg/L for T. rubrum) were used to classify isolates as wild-type or non–wild-type. Underlined SQLE alterations are associated with terbinafine MICs above the corresponding tentative epidemiological cutoff values. An expanded version of this table appears in the Appendix. DK-I, unassigned I; DK-II, unassigned II; EUCAST, European Committee on Antimicrobial Susceptibility Testing; ITS, internal transcribed spacer; ND, not determined; SNP, single-nucleotide polymorphism; SQLE, squalene epoxidase; WT, wild-type. ‡Modal MIC is reported only for distributions comprising >10 isolates. Bimodal distributions are reported as both modal MICs. §Indicates that all isolates of the indicated species were wild-type. DK-I and DK-II denote novel ITS genotypes identified in this study. ¶Indicates that the codon is not covered by sequencing of the short sqle fragment (spanning amino acids H376–V483). #EUCAST susceptibility testing was not performed.

Main Article

Page created: July 30, 2026
Page updated: August 18, 2026
Page reviewed: August 18, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external